blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0853485

EP0853485 - THERAPEUTIC ADMINISTRATION OF HEMOGLOBIN IN CARDIAC ARREST [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  22.10.2004
Database last updated on 14.09.2024
Most recent event   Tooltip22.10.2004Application deemed to be withdrawnpublished on 08.12.2004  [2004/50]
Applicant(s)For all designated states
Baxter International Inc.
One Baxter Parkway
Deerfield, IL 60015 / US
[N/P]
Former [1998/30]For all designated states
BAXTER INTERNATIONAL INC.
One Baxter Parkway
Deerfield, IL 60015 / US
Inventor(s)01 / BURHOP, Kenneth, E.
1230 Regent Drive
Mundelein, IL 60060 / US
02 / CHOW, Moses, S., S.
189 Highwood Drive
South Glastonbury, CT 06073 / US
[1998/30]
Representative(s)Bassett, Richard Simon, et al
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
[N/P]
Former [2002/30]Bassett, Richard Simon, et al
Eric Potter Clarkson, Park View House, 58 The Ropewalk
Nottingham NG1 5DD / GB
Former [1998/30]MacGregor, Gordon, et al
Eric Potter Clarkson, Park View House, 58 The Ropewalk
Nottingham NG1 5DD / GB
Application number, filing date96928960.220.08.1996
[1998/30]
WO1996US13512
Priority number, dateUS1995054011506.10.1995         Original published format: US 540115
[1998/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9712627
Date:10.04.1997
Language:EN
[1997/16]
Type: A1 Application with search report 
No.:EP0853485
Date:22.07.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 10.04.1997 takes the place of the publication of the European patent application.
[1998/30]
Search report(s)International search report - published on:US10.04.1997
(Supplementary) European search report - dispatched on:EP18.09.2000
ClassificationIPC:A61K38/16, A61K35/14, C07K14/00
[1998/30]
CPC:
A61K38/42 (EP,US); A61P9/00 (EP); A61P9/02 (EP)
C-Set:
A61K38/42, A61K2300/00 (EP,US)
Designated contracting statesBE,   CH,   DE,   FR,   GB,   IT,   LI,   NL,   SE [1998/30]
TitleGerman:THERAPEUTISCHE GABE VON HÄMOGLOBIN BEI HERZSTILLSTAND[1998/30]
English:THERAPEUTIC ADMINISTRATION OF HEMOGLOBIN IN CARDIAC ARREST[1998/30]
French:ADMINISTRATION THERAPEUTIQUE D'HEMOGLOBINE AU COURS D'UN ARRET CARDIAQUE[1998/30]
Entry into regional phase13.03.1998National basic fee paid 
13.03.1998Search fee paid 
13.03.1998Designation fee(s) paid 
13.03.1998Examination fee paid 
Examination procedure16.04.1997Request for preliminary examination filed
International Preliminary Examining Authority: US
13.03.1998Examination requested  [1998/30]
10.05.2002Despatch of a communication from the examining division (Time limit: M06)
11.11.2002Reply to a communication from the examining division
26.01.2004Communication of intention to grant the patent
08.06.2004Application deemed to be withdrawn, date of legal effect  [2004/50]
09.07.2004Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2004/50]
Fees paidRenewal fee
27.07.1998Renewal fee patent year 03
04.08.1999Renewal fee patent year 04
03.08.2000Renewal fee patent year 05
21.08.2001Renewal fee patent year 06
21.08.2002Renewal fee patent year 07
25.08.2003Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.08.200409   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US5194590  (SEHGAL LAKSHMAN R [US], et al) [X] 1-10,15,16 * col.3, l.26-54; col.4, l.28-40; claim 1 *
 [X]  - JESCH FH ET AL, "Oxygen-transporting fluids and oxygen delivery with hemodilution.", CRITICAL CARE MEDICINE, APR 1982, 10 (4) P270-4, UNITED STATES, XP000918364 [X] 1-10,15,16 * p.270, 2nd col., 1st full par., l.6-7); p.273-274, conclusions, see in part. p.274, 2nd full par. *
 [Y]  - DUNLAP ET AL, "Resuscitation with diaspirin crosslinked hemoglobin in a pig", ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, (1995), vol. 23, no. 1, pages 39 - 61, XP000917146 [Y] 1-10,15,16 * abstract *

DOI:   http://dx.doi.org/10.3109/10731199509117667
 [Y]  - LEONOV Y ET AL, "Hypertension with hemodilution prevents multifocal cerebral hypoperfusion after cardiac arrest in dogs.", STROKE, JAN 1992, 23 (1) P45-53, UNITED STATES, XP000918368 [Y] 1-10,15,16 * abstract, see in part. conclusions *
International search[Y]US5413558  (PARADIS NORMAN A [US]);
 [YP]US5498421  (GRINSTAFF MARK W [US], et al)
 [Y]  - ADULT BASIC LIFE SUPPORT. JAMA, 28 October 1992, Vol. 268, No. 16, "Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiac Care", pages 2184-2198.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.